James LaTorre, CFA

Loren Walensky, MD, PhD

James LaTorre, CFA

Chief Executive Officer

Rida Mourtada, PhD

Loren Walensky, MD, PhD

James LaTorre, CFA

Chief Scientific Officer

Loren Walensky, MD, PhD

Scientific Cofounder

Arianna Finnegan

Daniel Cohen, PhD

Loren Walensky, MD, PhD

Operations Manager

Daniel Cohen, PhD

Associate Principal Scientist, Protein Chemistry

Lip Nam Loh, PhD

Daniel Cohen, PhD

Associate Principal Scientist, Biology

Isabelle Hanna

Senior Research Associate, Biology

John Bajacan

Isabelle Hanna

Senior Research Associate, Chemistry

Scientific Advisory Board

James Balkovec, PhD

Steve Projan, PhD, FAAM

Joel Freundlich, PhD

Principal at ChemTract Consulting

Co-inventor of Caspofungin, the first glucan synthase inhibitor (GSi) for the treatment of serious fungal infections

Joel Freundlich, PhD

Steve Projan, PhD, FAAM

Joel Freundlich, PhD

Associate Professor

Pharmacology, Physiology & Neuroscience

New Jersey Medical School

Rutgers University

Steve Projan, PhD, FAAM

Former Head of the Infectious Diseases & Vaccines Innovative Medicines unit (iMED) at MedImmune

Former VP and Global Head of Infectious Diseases at the Novartis Institutes for Biomedical Research

James LaTorre, CFA

Loren Walensky, MD, PhD

James LaTorre, CFA

Rida Mourtada, PhD

Loren Walensky, MD, PhD

James LaTorre, CFA

Loren Walensky, MD, PhD

Loren Walensky, MD, PhD

Loren Walensky, MD, PhD

Arianna Finnegan

Daniel Cohen, PhD

Loren Walensky, MD, PhD

Daniel Cohen, PhD

Daniel Cohen, PhD

Daniel Cohen, PhD

Lip Nam Loh, PhD

Daniel Cohen, PhD

Daniel Cohen, PhD

Isabelle Hanna

Isabelle Hanna

Isabelle Hanna

John Bajacan

Isabelle Hanna

Isabelle Hanna

Scientific Advisory Board

James Balkovec, PhD

Steve Projan, PhD, FAAM

Joel Freundlich, PhD

Joel Freundlich, PhD

Steve Projan, PhD, FAAM

Joel Freundlich, PhD

Steve Projan, PhD, FAAM

Steve Projan, PhD, FAAM

Steve Projan, PhD, FAAM

Cookie Policy